Pfizer-J&J Alzheimer’s Drug Fails to Aid Cognition

Pfizer Inc., Johnson & Johnson and Elan Corp.’s experimental Alzheimer’s treatment failed to improve symptoms of dementia in the first of four pivotal studies testing the drug.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.